⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

March 14, 2022Advances in TherapyOpen Access

Clinical Remission in Severe Asthma: A Pooled Post Hoc Analysis of the Patient Journey with Benralizumab

Andrew Menzies‐Gow Flavia Hoyte David Price David Cohen Peter Barker James L. Kreindler Maria Jison Christopher Brooks Peggy Papeleu Rohit Katial

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

Sirocco (Nct01928771); Calima (Nct01914757); Zonda (Nct02075255).

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Menzies‐Gow et al. (2022) studied this question.

synapsesocial.com/papers/69defaec5e217d93a5559249 https://doi.org/10.1007/s12325-022-02098-1

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016Original Research · 2017 · 13,221 citations
2International ERS/ATS guidelines on definition, evaluation and treatment of severe asthmaNarrative Review · 2013 · 3,925 citations
3Characterisation of patients with severe asthma in the UK Severe Asthma Registry in the biologic eraRegistry Study · 2020 · 153 citations
4Characterization of Severe Asthma WorldwideRegistry Study · 2019 · 352 citations
5Eosinophilic and Noneosinophilic AsthmaRegistry Study · 2021 · 282 citations

More related papers

“T2-high” in severe asthma related to blood eosinophil, exhaled nitric oxide and serum periostin2018
Different endotypes and phenotypes drive the heterogeneity in severe asthma2019
Development and validation of a questionnaire to measure asthma control1999

More from Advances in Therapy

Cost-Effectiveness of Lisocabtagene Maraleucel Versus Axicabtagene Ciloleucel as Second-Line Treatment for Large B Cell Lymphoma in the United StatesFri,
Impact of Budesonide/Glycopyrronium/Formoterol Initiation on Healthcare Resource Utilization and Estimated Associated Costs and Greenhouse Gas Emissions Across COPD Care in Spain (ORESTES* Study)Wed,